Refractory testicular germ cell tumors are highly sensitive to the second generation DNA methylation inhibitor guadecitabine.
Oncotarget
; 8(2): 2949-2959, 2017 Jan 10.
Article
in En
| MEDLINE
| ID: mdl-27936464
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Azacitidine
/
Testicular Neoplasms
/
Neoplasms, Germ Cell and Embryonal
/
Drug Resistance, Neoplasm
/
DNA Methylation
/
Antineoplastic Agents
Type of study:
Diagnostic_studies
/
Prognostic_studies
Limits:
Animals
/
Humans
/
Male
Language:
En
Journal:
Oncotarget
Year:
2017
Document type:
Article
Affiliation country:
United States
Country of publication:
United States